ArticleImmunology2012
The formation of P particle increased immunogenicity of norovirus P protein.
Article in Immunology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed, 12 citations in OpenAlex.
- Recent advancements in combination subunit vaccine development.Human vaccines & immunotherapeutics · 2017Article
- Norovirus Binding to Ligands Beyond Histo-Blood Group Antigens.Frontiers in microbiology · 2017Review
- Norovirus.Clinical microbiology reviews · 2015Review
- Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.Journal of virology · 2014Article
- Polyvalent complexes for vaccine development.Biomaterials · 2013Article
- Article
- Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus.Nanomedicine (London, England) · 2012Review
- Norovirus vaccines and potential antinorovirus drugs: recent advances and future perspectives.Future virologyArticle
Corrections and comments
- Comment on
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
Abstract
As a commentary on a recently published paper in Immunology, this article summaries the principle of norovirus P particle as a promising vaccine against noroviruses. It emphasizes the importance of P particle formation in the immune enhancement of the vaccine and methods for production/verification of high quality P particles which may be easily neglected by researchers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.